INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
SEC FORM 4/Tax withholdingVerified data

Veillon-Berteloot Chantal reported IART

EVP & CHRO · INTEGRA LIFESCIENCES HOLDINGS CORP · Common Stock

Side
F
Value
$52K
Shares
5,420
Price
$9.61
Executed
Mar 11, 2026
Disclosed
Mar 12, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Mar 11 executedMar 12, 2026 disclosed

IART · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
20/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Tax withholding — administrative, little informational value

  • Relative size+12 / 25

$52K reported value · 32.2% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · IART

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    19
    VC
    Veillon-Berteloot ChantalEVP & CHRO
    IARTINTEGRA LIFESCIENCES HOLDINGS CORP
    Tax withholding
    		F$24K
    1,455 sh
    		Sep 1, 2026Sep 4, 2026
    traded Sep 1, 2026
    		+3dSEC FORM 4

    Evidence

    16
    KD
    Knight Lea DanielsEVP & Chief Financial Officer
    IARTINTEGRA LIFESCIENCES HOLDINGS CORP
    Tax withholding
    		F$94K
    5,226 sh
    		Jul 3, 2026Jul 6, 2026
    traded Jul 3, 2026
    		+3dSEC FORM 4

    Evidence

    9
    LW
    Lo Renee WonlaiDirector
    IARTINTEGRA LIFESCIENCES HOLDINGS CORP
    Grant or award
    		A—
    17.7K sh
    		May 7, 2026May 11, 2026
    traded May 7, 2026
    		+4dSEC FORM 4

    Evidence

    9
    CS
    Clay ShaundraDirector
    IARTINTEGRA LIFESCIENCES HOLDINGS CORP
    Grant or award
    		A—
    17.7K sh
    		May 7, 2026May 11, 2026
    traded May 7, 2026
    		+4dSEC FORM 4

    Evidence

    13
    SH
    Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
    IARTINTEGRA LIFESCIENCES HOLDINGS CORP
    Option exercise
    		M—
    1,216 sh
    		Mar 10, 2026Mar 12, 2026
    traded Mar 10, 2026
    		+2dSEC FORM 4

    Evidence

    9
    SH
    Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
    IARTINTEGRA LIFESCIENCES HOLDINGS CORP
    Tax withholding
    		F$8,274
    861 sh
    		Mar 11, 2026Mar 12, 2026
    traded Mar 11, 2026
    		+1dSEC FORM 4

    Evidence

    21
    SH
    Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
    IARTINTEGRA LIFESCIENCES HOLDINGS CORP
    Option exercise
    		M—
    18.9K sh
    		Mar 11, 2026Mar 12, 2026
    traded Mar 11, 2026
    		+1dSEC FORM 4

    Evidence

    13
    SH
    Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
    IARTINTEGRA LIFESCIENCES HOLDINGS CORP
    Tax withholding
    		F$50K
    5,190 sh
    		Mar 11, 2026Mar 12, 2026
    traded Mar 11, 2026
    		+1dSEC FORM 4

    Evidence

    13
    SH
    Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
    IARTINTEGRA LIFESCIENCES HOLDINGS CORP
    Option exercise
    		M—
    1,216 sh
    		Mar 10, 2026Mar 12, 2026
    traded Mar 10, 2026
    		+2dSEC FORM 4

    Evidence

    13
    SH
    Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
    IARTINTEGRA LIFESCIENCES HOLDINGS CORP
    Option exercise
    		M—
    2,356 sh
    		Mar 11, 2026Mar 12, 2026
    traded Mar 11, 2026
    		+1dSEC FORM 4

    Evidence

    9
    SH
    Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
    IARTINTEGRA LIFESCIENCES HOLDINGS CORP
    Option exercise
    		M—
    16.6K sh
    		Mar 11, 2026Mar 12, 2026
    traded Mar 11, 2026
    		+1dSEC FORM 4

    Evidence

    21
    SH
    Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
    IARTINTEGRA LIFESCIENCES HOLDINGS CORP
    Grant or award
    		A—
    60.9K sh
    		Mar 11, 2026Mar 12, 2026
    traded Mar 11, 2026
    		+1dSEC FORM 4

    Evidence

    9
    SH
    Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
    IARTINTEGRA LIFESCIENCES HOLDINGS CORP
    Tax withholding
    		F$5,740
    601 sh
    		Mar 10, 2026Mar 12, 2026
    traded Mar 10, 2026
    		+2dSEC FORM 4

    Evidence

    9
    VC
    Veillon-Berteloot ChantalEVP & CHRO
    IARTINTEGRA LIFESCIENCES HOLDINGS CORP
    Grant or award
    		A—
    41.8K sh
    		Mar 11, 2026Mar 12, 2026
    traded Mar 11, 2026
    		+1dSEC FORM 4

    Evidence

    16
    KD
    Knight Lea DanielsEVP & Chief Financial Officer
    IARTINTEGRA LIFESCIENCES HOLDINGS CORP
    Tax withholding
    		F$78K
    8,089 sh
    		Mar 11, 2026Mar 12, 2026
    traded Mar 11, 2026
    		+1dSEC FORM 4

    Evidence

    9
    KD
    Knight Lea DanielsEVP & Chief Financial Officer
    IARTINTEGRA LIFESCIENCES HOLDINGS CORP
    Grant or award
    		A—
    111.2K sh
    		Mar 11, 2026Mar 12, 2026
    traded Mar 11, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001990905-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Mar 11, 2026
    Published
    Mar 12, 2026
    Ingested by INSIDER
    Nov 5, 04:12 UTC
    Last re-read
    Nov 5, 04:12 UTC

    Extracted facts

    Filer
    Veillon-Berteloot Chantal
    Role
    EVP & CHRO
    Transaction
    Tax withholdingAs filed: “F”
    Asset
    INTEGRA LIFESCIENCES HOLDINGS CORP
    Ticker
    IART
    Shares
    5,420
    Price per share
    $9.61
    Value
    $52,086
    Execution date (reported)
    Mar 11, 2026
    Owned after transaction
    22.2K shares
    Days from execution to publication
    1

    Calculation

    Value = shares × reported price per share

    • Shares: 5,420
    • Price: $9.61

    = $52,086

    What this establishes

    Veillon-Berteloot Chantal filed this Form 4 reporting a tax withholding of IART on Mar 11, 2026. It became public on Mar 12, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    EVP & CHRO
    Veillon-Berteloot Chantalcik:0001990905
    Issuer
    INTEGRA LIFESCIENCES HOLDINGS CORPcik:0000917520

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.